Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetic Foot Ulcer

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...

Peptic Ulcer

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...

Determinants of Bacterial Pathogenicity and Virulence

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...

The Proteasome

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

The Proteasome

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...

The Proteasome

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Peptide ligands to explore interactions with intrinsically disordered multidomain proteins: the case of SARS-CoV-2 nucleocapsid protein.

Scientific reports·2026

Same author

Measurement of the <sup>235</sup>U fission cross section relative to the standard <sup>10</sup>B(n, α) reaction at the CERN n_TOF facility: Results for E<sub>n</sub>< 2 eV.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2025

Same author

Neutron capture measurements for s-process nucleosynthesis: A review about CERN n_TOF developments and contributions.

The European physical journal. A, Hadrons and nuclei·2025

Same author

Shedding Light on the Origin of ^{204}Pb, the Heaviest s-Process-Only Isotope in the Solar System.

Physical review letters·2024

Same author

Measurement of the ^{140}Ce(n,γ) Cross Section at n_TOF and Its Astrophysical Implications for the Chemical Evolution of the Universe.

Physical review letters·2024

Same author

The Sapienza University of Rome network of automated external defibrillators: a prototype webMap developed to speed access to community defibrillators and increase survival from out-of-hospital cardiac arrest.

European review for medical and pharmacological sciences·2023

Same journal

Mechanistic factors of cardiovascular diseases.

Minerva cardioangiologica·2020

Same journal

Robotic-assisted coronary artery bypass grafting: current knowledge and future perspectives.

Minerva cardioangiologica·2020

Same journal

Features of degenerative mitral valve prolapse in the North East of China: repair characteristics, and short-term follow-up results.

Minerva cardioangiologica·2020

Same journal

Myocardial revascularization in chronic coronary syndromes: does viability matter?

Minerva cardioangiologica·2020

Same journal

Extracorporeal membrane oxygenation for COVID-19: effective weapon or futile effort?

Minerva cardioangiologica·2020

Same journal

Heart and endurance sports: excesses are often unhealthy.

Minerva cardioangiologica·2020

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 3, 2026

Protocol to Create Chronic Wounds in Diabetic Mice

Protocol to Create Chronic Wounds in Diabetic Mice

Published on: September 25, 2019

Proteases and chronic leg ulcers.

G Failla¹, S Campo, G Ardita

¹Department of Angiology, Vittorio Emanuele Ferrarotto, S. Bambino Hospital, Catania, Italy. giacomofailla@msn.com

Minerva Cardioangiologica

|July 11, 2008

Summary

This summary is machine-generated.

Cadexomer iodine significantly accelerated healing of chronic leg ulcers more effectively than compression therapy. This topical treatment demonstrated a greater reduction in wound surface area over a 28-day period.

Related Experiment Videos

Last Updated: Jul 3, 2026

Protocol to Create Chronic Wounds in Diabetic Mice

Protocol to Create Chronic Wounds in Diabetic Mice

Published on: September 25, 2019

Area of Science:

Dermatology and Wound Care
Biomaterials Science

Background:

Chronic leg ulcers represent a significant clinical challenge with limited effective treatment options.
Compression therapy is a standard treatment, but alternative or adjunctive therapies are needed.

Purpose of the Study:

To compare the efficacy of cadexomer iodine in reducing leg ulcer surface area against standard compression therapy.
To evaluate the wound size reduction index and percentage reduction in wound size for both treatment groups.

Main Methods:

Two groups of leg ulcer patients were treated: one with cadexomer iodine and a control group with compression therapy.
Wound surface area was measured at baseline and after 28 days.
Calculations included average wound surface area reduction, percent reduction, and weekly reduction index.

Main Results:

Cadexomer iodine treatment resulted in a total wound area reduction of 9.67 cm²/week, significantly higher than compression therapy (6.11 cm²/week).
The average wound size reduction was 43% with cadexomer iodine compared to 28% with compression therapy.
The weekly wound size reduction index was also notably higher in the cadexomer iodine group (0.96 cm²) versus the control group (0.61 cm²).

Conclusions:

Cadexomer iodine demonstrates superior efficacy in promoting the healing of chronic leg ulcers compared to compression therapy alone.
These findings suggest cadexomer iodine is a valuable therapeutic option for managing chronic leg ulcers.